8-K 1 v151284_8k.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
__________________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):         June 1, 2009

IMMUCOR, INC.
(Exact name of registrant as specified in its charter)


Georgia
0-14820
22-2408354
(State or other jurisdiction
(Commission
(IRS Employer
of incorporation)
File Number)
Identification No.)

3130 Gateway Drive, P.O. Box 5625, Norcross, Georgia
 
30091-5625
(Address of principal executive offices)
 
(Zip Code)

Registrant's telephone number, including area code: (770) 441-2051

Not Applicable
(Former name or former address,
if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 
 

 
Item 8.01
Other Events.
 
Immucor Announces Fiscal Year 2010 Guidance.  On June 1, 2009, Immucor, Inc. issued a press release announcing its financial guidance for the fiscal year ending May 31, 2010.  The press release is attached hereto as Exhibit 99.1.
 

 
Item 9.01
Financial Statements and Exhibits.
 
 
 
(a)
Not applicable.

 
(b)
Not applicable.

 
(c)
Not applicable.

 
(d)
Exhibits.


EXHIBIT NUMBER
 
DESCRIPTION
     
99.1
 
Press Release dated June 1, 2009
     
 
 
 

 
 

 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 
IMMUCOR, INC.
 
 
 
 
Date:  June 1, 2009
By:
 /s/ Philip H. Moïse                            
   
Philip H. Moïse
   
Vice President and General Counsel